ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1681

An Evaluation of Two Novel Techniques Utilising a Smartphone Digital Camera in the Assessment of Nailfold Capillaries in Suspected Scleroderma-Spectrum Disorders: A Single-Center Cross-Sectional Study

Matthew Parker1,2, Neil McGill1,2 and Michael Oliffe1, 1Rheumatology, Royal Prince Alfred Hospital, Sydney, Australia, 2University of Sydney, Sydney, Australia

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Capillaroscopy, diagnostic imaging and scleroderma

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 6, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster II

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose:

Nailfold capillaroscopy is a non-invasive, sensitive and specific technique used in the diagnosis of scleroderma-spectrum disorders. Abnormalities predict progression from Raynauds phenomenon to connective tissue disease, sometimes years in advance, as well as serious complications such as pulmonary hypertension. Its inclusion in the most recent diagnostic criteria for systemic sclerosis enable them to perform better to identify patients with early systemic sclerosis in particular, important for prognostication, risk stratification, screening regimens and hopefully, in future, therapeutic intervention.

The current gold standard techniques are nailfold videocapillaroscopy and widefield microscopy. The equipment required for both remains expensive and relatively inaccessible, typically only available in centers with a special interest. Novel approaches utilizing new technologies may help improve accessibility to the wider rheumatology community.  

We sought to evaluate the novel combination of a smartphone digital camera with two devices, a commercially produced lens attachment and a dermatoscope, with both techniques offering the possibility of a rapid bedside evaluation at a fraction of the cost of other techniques.

Objectives:

The primary aim was to evaluate the diagnostic performance of digital photographs taken with a smartphone camera using both a lens attachment and, separately, a dermatoscope. The secondary aims were to assess the influence of prior capillaroscopy experience and familiarity with the novel techniques on diagnostic accuracy.

Methods:

This was a single-center cross-sectional study. All patients referred for capillaroscopy between May 2016 and January 2017 were eligible for inclusion.  Patients nailfolds were classified by widefield microscopy before proceeding, double-blinded, to have their nailfolds photographed using both novel techniques. Randomized photographs were assessed after the completion of enrolment by three independent investigators. Sensitivity, specificity, inter- and intra-observer variability were calculated.

Results:

65 participants contributed 1040 digital photographs for independent assessment by three investigators. The smartphone-lens technique performed with moderate sensitivity (65%; 58-72) and high specificity (90%; 84-96). The smartphone-dermatoscope technique performed with higher sensitivity (74%; 66-82) and excellent specificity (95%; 88-100) and was used more accurately by a novice. Prior assessor experience with nailfold capillaroscopy in general and prior experience with the novel techniques positively modulated the diagnostic accuracy.

Conclusion:

New technologies, in this case utilising a smartphone camera, could help improve accessibility to nailfold capillaroscopy, an important diagnostic tool and putative biomarker in scleroderma-spectrum disorders, whilst retaining accurate results.

 

Capillaroscopy Experience

 

True Positive (n)

True Negative (n)

False Positive (n)

False Negative (n)

Sensitivity (CI)

Specificity

(CI)

Novice

SMARTPHONE-LENS

12

36

6

11

52% (45-59)

86% (80-92)

SMARTPHONE-DERMATOSCOPE

16

38

4

7

70% (62-78)

90% (84-96)

Intermediate

SMARTPHONE-LENS

15

41

1

8

65% (58-72)

98% (91-100)

SMARTPHONE-DERMATOSCOPE

17

41

1

6

74% (66-82)

98% (91-100)

Expert

SMARTPHONE-LENS

15

38

4

8

65% (58-72)

90% (84-96)

SMARTPHONE-DERMATOSCOPE

17

40

2

6

74% (66-82)

95% (88-100)

 


Disclosure: M. Parker, None; N. McGill, None; M. Oliffe, None.

To cite this abstract in AMA style:

Parker M, McGill N, Oliffe M. An Evaluation of Two Novel Techniques Utilising a Smartphone Digital Camera in the Assessment of Nailfold Capillaries in Suspected Scleroderma-Spectrum Disorders: A Single-Center Cross-Sectional Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/an-evaluation-of-two-novel-techniques-utilising-a-smartphone-digital-camera-in-the-assessment-of-nailfold-capillaries-in-suspected-scleroderma-spectrum-disorders-a-single-center-cross-sectional-study/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/an-evaluation-of-two-novel-techniques-utilising-a-smartphone-digital-camera-in-the-assessment-of-nailfold-capillaries-in-suspected-scleroderma-spectrum-disorders-a-single-center-cross-sectional-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology